2022 annual financial data
4D Molecular Therapeutics 2022 Operating margin
Direct answer
Operating margin was -3,516.52%.
Operating income was -110,032,000 USD and net income was -101,076,000 USD.
Operating cash flow was -86,685,000 USD.
Get free 4D Molecular Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,129,000 USD
- Operating income
- -110,032,000 USD
- Net income
- -101,076,000 USD
- Operating cash flow
- -86,685,000 USD